During the past decade, Beijing Shijitan Hospital conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 3 clinical trials were completed, i.e. on average, 5.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 2 clinical trials were completed. i.e. 8.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Shijitan Hospital" #1 sponsor was "Capital Medical University" with 13 trials, followed by "United Therapeutics" with 7 trials sponsored, "Beijing Shijitan Hospital, Capital Medical University" with 5 trials sponsored, "Peking University First Hospital" with 5 trials sponsored and "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 5 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Shijitan Hospital" #1 collaborator was "Beijing Shijitan Hospital, Capital Medical University" with 11 trials as a collaborator, "Beijing 302 Hospital" with 4 trials as a collaborator, "Duke University" with 4 trials as a collaborator, "The Third Xiangya Hospital of Central South University" with 4 trials as a collaborator and "Peking University People's Hospital" with 3 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Shijitan Hospital" are "Pulmonary Arterial Hypertension" (8 trials), "Neoplasms" (5 trials), "Allergic Rhinitis" (4 trials), "Healthy" (4 trials) and "Hypertension, Portal" (4 trials). Many other conditions were trialed in "Beijing Shijitan Hospital" in a lesser frequency.

Most popular intervention types in "Beijing Shijitan Hospital" are "Drug" (49 trials), "Biological" (11 trials), "Other" (10 trials), "Procedure" (7 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "HVPG measurement" (3 trials), "Propofol" (3 trials), "Sevoflurane" (3 trials) and "AIT drops" (2 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Shijitan Hospital" are 71 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 19 active trials in "Beijing Shijitan Hospital". 2 are not yet recruiting, 12 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 33 completed trials in Beijing Shijitan Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Shijitan Hospital, 19 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 22 trials that are defined as “Not Applicable".